(Q44437917)

3 December 2017

title

Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience (English)

1 reference

3 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00351-8

1 January 2024

author name string

B. D. Kahan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

R. Knight

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

L. Schoenberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

J. Pobielski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

R. H. Kerman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

K. Mahalati

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

Y. Yakupoglu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

F. T. Aki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

S. Katz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

C. T. Van Buren

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742465

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0041134503003518?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00351-8

https://api.elsevier.com/content/article/PII:S0041134503003518?httpAccept=text/plain

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00351-8

Transplantation Proceedings

1 January 2024

published in

1 reference

3 December 2017

volume

35

1 reference

3 December 2017

issue

3 Suppl

1 reference

3 December 2017

page(s)

25S-34S

1 reference

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Rapamycin for immunosuppression in organ allografting.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: racial differences in bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Median effect analysis of efficacy versus adverse effects of immunosuppressants

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Case report--sirolimus rescue therapy for refractory renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Sirolimus permits steroid withdrawal from a cyclosporine regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Sirolimus rescue therapy for refractory rejection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900351-8

7 January 2021

Medical science research

3

17

877

Morris

1989

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00351-8

1 January 2024

Identifiers

1 reference

3 December 2017

1 reference